6th Edition of Cardiology World Conference
September 15-17, 2025 | London, UK
Nanotechnology and Cardiovascular Medicine
Incorporating nanotechnology into the field of cardiovascular medicine is paving the way for new treatments that were once unimaginable. Nanotechnology and cardiovascular medicine are being combined to develop more precise drug delivery systems, allowing medication to be delivered directly to the heart, reducing systemic side effects and improving therapeutic outcomes. This breakthrough is also enhancing diagnostic tools, enabling earlier detection of cardiovascular diseases. The potential for nanomaterials to repair or regenerate damaged tissues and blood vessels provides a hopeful outlook for patients suffering from severe cardiovascular diseases. As this field continues to evolve, the integration of nanotechnology promises to redefine the future of heart disease management.
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Gustavo Lionel Knop
Mayo Clinic, United States
Arthur J Siegel
Massachusetts General Hospital, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Iris Panagiota Efthymiou
University of Greenwich, United Kingdom
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, GermanySubmit your abstract Today
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The low grade chronic inflammation and atherosclerosis
Sekib Sokolovic, Sarajevo School of Science and Technology, Medical Faculty, ASA Hospital, Bosnia and Herzegowina